Literature DB >> 16809764

Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation.

Heehyoung Lee1, Nilanjan Sengupta, Alejandro Villagra, Natalie Rezai-Zadeh, Edward Seto.   

Abstract

Histone deacetylases (HDACs) are enzymes that regulate the functions of histones as well as nonhistones by catalyzing the removal of acetyl groups from lysine residues. HDACs regulate many biological processes, including the cell division cycle and tumorigenesis. Although recent studies have implicated HDAC8 in tumor cell proliferation, the molecular mechanisms linking HDAC8 to cell growth remain unknown. Here, we report that the human ortholog of the yeast ever-shorter telomeres 1B (EST1B) binds HDAC8. This interaction is regulated by protein kinase A-mediated HDAC8 phosphorylation and protects human EST1B (hEST1B) from ubiquitin-mediated degradation. Phosphorylated HDAC8 preferentially recruits Hsp70 to a complex that inhibits the CHIP (C-terminal heat shock protein interacting protein) E3 ligase-mediated degradation of hEST1B. Importantly, HDAC8 regulation of hEST1B protein stability modulates total telomerase enzymatic activity. Our findings reveal a novel mechanism by which HDAC8 contributes to tumorigenesis by regulating telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809764      PMCID: PMC1592721          DOI: 10.1128/MCB.01971-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

Review 1.  Telomerase regulation: not just flipping the switch.

Authors:  Dara L Aisner; Woodring E Wright; Jerry W Shay
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

2.  CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein.

Authors:  S Murata; Y Minami; M Minami; T Chiba; K Tanaka
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

3.  Fission yeast F-box protein Pof3 is required for genome integrity and telomere function.

Authors:  Satoshi Katayama; Kenji Kitamura; Anna Lehmann; Osamu Nikaido; Takashi Toda
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

Review 4.  Histone deacetylases and cancer: causes and therapies.

Authors:  P Marks; R A Rifkind; V M Richon; R Breslow; T Miller; W K Kelly
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

Review 5.  Telomerase as a therapeutic target for malignant gliomas.

Authors:  Tadashi Komata; Takao Kanzawa; Yasuko Kondo; Seiji Kondo
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

6.  The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.

Authors:  Mi Hou; XiongBiao Wang; Nikita Popov; Anju Zhang; Xiaoyan Zhao; Rong Zhou; Anders Zetterberg; Magnus Björkholm; Marie Henriksson; Astrid Gruber; Dawei Xu
Journal:  Exp Cell Res       Date:  2002-03-10       Impact factor: 3.905

7.  Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family.

Authors:  Lin Gao; Maria A Cueto; Fred Asselbergs; Peter Atadja
Journal:  J Biol Chem       Date:  2002-04-10       Impact factor: 5.157

8.  Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70.

Authors:  Colin A Johnson; Darren A White; Jayne S Lavender; Laura P O'Neill; Bryan M Turner
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

9.  Est1p as a cell cycle-regulated activator of telomere-bound telomerase.

Authors:  Andrew K P Taggart; Shu-Chun Teng; Virginia A Zakian
Journal:  Science       Date:  2002-08-09       Impact factor: 47.728

10.  CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.

Authors:  Yuzuru Imai; Mariko Soda; Shigetsugu Hatakeyama; Takumi Akagi; Tsutomu Hashikawa; Kei Ichi Nakayama; Ryosuke Takahashi
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

View more
  37 in total

1.  HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity.

Authors:  Wei-Kai Hua; Jing Qi; Qi Cai; Emily Carnahan; Maria Ayala Ramirez; Ling Li; Guido Marcucci; Ya-Huei Kuo
Journal:  Blood       Date:  2017-10-30       Impact factor: 22.113

2.  Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.

Authors:  Soon-Duck Ha; Chantelle Reid; Shahab Meshkibaf; Sung Ouk Kim
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

3.  HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals.

Authors:  Panpan An; Feng Chen; Zihan Li; Yuyi Ling; Yanxi Peng; Haisheng Zhang; Jiexin Li; Zhuojia Chen; Hongsheng Wang
Journal:  Oncogene       Date:  2020-06-04       Impact factor: 9.867

4.  HDAC8-mediated epigenetic reprogramming plays a key role in resistance to anthrax lethal toxin-induced pyroptosis in macrophages.

Authors:  Soon-Duck Ha; Chae Young Han; Chantelle Reid; Sung Ouk Kim
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

5.  SIRT1 is a transcriptional enhancer of the glucocorticoid receptor acting independently to its deacetylase activity.

Authors:  Shigeru Suzuki; James R Iben; Steven L Coon; Tomoshige Kino
Journal:  Mol Cell Endocrinol       Date:  2017-09-18       Impact factor: 4.102

6.  HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides.

Authors:  Carol Ann Castañeda; Noah A Wolfson; Katherine R Leng; Yin-Ming Kuo; Andrew J Andrews; Carol A Fierke
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

7.  Phosphorylation of Histone Deacetylase 8: Structural and Mechanistic Analysis of the Phosphomimetic S39E Mutant.

Authors:  Katherine R Welker Leng; Carol Ann Castañeda; Christophe Decroos; Barira Islam; Shozeb M Haider; David W Christianson; Carol A Fierke
Journal:  Biochemistry       Date:  2019-11-04       Impact factor: 3.162

8.  Expression of Class I Histone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain.

Authors:  Svetlana Demyanenko; Maria Neginskaya; Elena Berezhnaya
Journal:  Transl Stroke Res       Date:  2017-12-07       Impact factor: 6.829

9.  Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.

Authors:  Daniel P Dowling; Stephanie L Gantt; Samuel G Gattis; Carol A Fierke; David W Christianson
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

10.  Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease.

Authors:  Sida Shen; Veronick Benoy; Joel A Bergman; Jay H Kalin; Mariana Frojuello; Giulio Vistoli; Wanda Haeck; Ludo Van Den Bosch; Alan P Kozikowski
Journal:  ACS Chem Neurosci       Date:  2015-12-07       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.